Effects of synbiotic on anthropometry, lipid profile and oxidative stress in obese children

N Ipar1, S Durmus Aydogdu2, G Kilic Yildirim2

  • 11 Eskisehir Osmangazi University Faculty of Medicine, Department of Pediatrics, 26480 Eskisehir, Turkey.

Beneficial Microbes
|August 12, 2015
PubMed

Insights

Synbiotic supplementation in children with obesity significantly reduced weight, body mass index, and improved lipid profiles and oxidative stress markers. This intervention shows promise for managing pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Microbiome Research

Background:

  • Limited data exists on the effects of probiotics and prebiotics on childhood obesity.
  • Obesity in children and adolescents is a growing public health concern.
  • Synbiotics, combining probiotics and prebiotics, may offer therapeutic benefits.

Purpose of the Study:

  • To evaluate the effects of synbiotic supplementation on anthropometric measurements in obese children.
  • To assess the impact of synbiotics on lipid profiles in pediatric obesity.
  • To investigate the influence of synbiotics on oxidative stress parameters in obese children.

Main Methods:

  • An open-label, randomized controlled study involving children with primary obesity.
  • Group 1: Standard care (reduced calorie intake, increased physical activity).
  • Group 2: Standard care plus daily synbiotic supplementation for one month.

Main Results:

  • One month of synbiotic supplementation significantly reduced weight (P<0.001) and body mass index (P<0.01).
  • Synbiotic group showed significantly greater reductions in anthropometric measurements (P<0.05).
  • Synbiotic intervention led to significant declines in serum total cholesterol, LDL cholesterol, and total oxidative stress (P<0.05).

Conclusions:

  • Synbiotic supplementation demonstrated beneficial effects on weight, BMI, lipid profile, and oxidative stress in obese children.
  • This study is among the first to show synbiotics' effects on oxidative stress in obese patients, with added weight loss benefits.
  • Synbiotics represent a potential adjunctive therapy for managing pediatric obesity.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
287
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762